Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort

Introduction: Lopinavir/ritonavir-based antiretroviral therapy (ART) is recommended for all HIV-infected children less than three years. However, little is known about its field implementation and effectiveness in West Africa. We assessed the 12-month response to lopinavir/ritonavir-based antiretrov...

Descripción completa

Detalles Bibliográficos
Autores principales: Amani-Bosse, Clarisse, Dahourou, Désiré Lucien, Malateste, Karen, Amorissani-Folquet, Madeleine, Coulibaly, Malik, Dattez, Sophie, Emieme, Arlette, Barry, Mamadou, Rouzioux, Christine, N’gbeche, Sylvie, Yonaba, Caroline, Timité-Konan, Marguerite, Mea, Véronique, Ouédraogo, Sylvie, Blanche, Stéphane, Meda, Nicolas, Seguin-Devaux, Carole, Leroy, Valériane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515025/
https://www.ncbi.nlm.nih.gov/pubmed/28453240
http://dx.doi.org/10.7448/IAS.20.01.21362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515025/
https://www.ncbi.nlm.nih.gov/pubmed/28453240
http://dx.doi.org/10.7448/IAS.20.01.21362

Ejemplares similares